Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Pharmaceuticals
NYC Drug Discovery Institute Launches
by Lisa M. Jarvis
October 14, 2013
| A version of this story appeared in
Volume 91, Issue 41
The Tri-Institutional Therapeutics Discovery Institute, a collaboration among three New York City-based academic centers, has launched with $20 million in philanthropic funding. The partnership among Memorial Sloan-Kettering Cancer Center, Rockefeller University, and Weill Cornell Medical College brings together experts in medicinal chemistry, compound screening, and drug development. Medicinal chemistry will take place at labs that are set to open in January at Weill Cornell. The nonprofit institute has partnered with Takeda Pharmaceutical to develop small-molecule drugs.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter